Cargando…
Meeting the affordability challenges posed by orphan drugs: a survey of payers, providers, and employers
BACKGROUND: As an increasing number of orphan drugs are FDA approved, health care payers, employers, and providers are attempting to strike a balance between patient access to innovative treatments and overall affordability. Payers and employers are evaluating how traditional specialty pharmacy mana...
Autores principales: | Lopata, Erin, Terrone, Christopher, Gopalan, Ami, Ladikos, Nicholas, Richardson, Terry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394181/ https://www.ncbi.nlm.nih.gov/pubmed/33586514 http://dx.doi.org/10.18553/jmcp.2021.20553 |
Ejemplares similares
-
Opportunities and challenges surrounding financial models for high-investment medications: A survey of access decision-makers and employers
por: Lopata, Erin, et al.
Publicado: (2023) -
Are payers treating orphan drugs differently?
por: Cohen, Joshua P., et al.
Publicado: (2014) -
The availability and affordability of orphan drugs for rare diseases in China
por: Gong, Shiwei, et al.
Publicado: (2016) -
Changes in Payer Mix and Physician Reimbursement After the Affordable Care Act and Medicaid Expansion
por: Jones, Christine D., et al.
Publicado: (2015) -
Access to Affordable Orphan Medicines in Europe: An EHA Position Paper
por: Merlini, Giampaolo, et al.
Publicado: (2020)